Abbott Laboratories

NYSE:ABTUnited States

Sep 5, 2024

Show headlines and story abstract

• DJ How to Play the Market Now: The Case for Defensive Value Stocks -- Barrons.com, from 3:18PM ET on Thursday Sep 05, 2024 by Dow Jones

  3:18PM ET on Thursday Sep 05, 2024 by Dow Jones
  Companies Mentioned: PM, MO, ABT, CL, COST
  
  By Teresa Rivas
  
  The historically painful month of September is off to a bad start for stocks, so it makes sense that one of the Street's more cautious strategists sees reasons to expect more downbeat news. But that doesn't mean he sees no opportunities.
  

• Abbott Laboratories' Lingo Glucose Monitor System Available in US, from 9:44AM ET on Thursday Sep 05, 2024 by MT Newswires

  9:44AM ET on Thursday Sep 05, 2024 by MT Newswires
  Companies Mentioned: ABT
  09:44 AM EDT, 09/05/2024 (MT Newswires) -- Abbott Laboratories (ABT) said Thursday that its first continuous glucose monitoring system that does not require a prescription is available in the US. The system, Lingo, has a biosensor and a mobile app a...

• Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S., from 9:01AM ET on Thursday Sep 05, 2024 by PR Newswire

  9:01AM ET on Thursday Sep 05, 2024 by PR Newswire
  Companies Mentioned: ABT

  -- Designed for people interested in improving their overall health and wellness

  -- Provides real-time glucose data and personal coaching insights based on the body's reaction to nutrition, exercise and life's daily stressors

• Abbott's Lingo(TM) Continuous Glucose Monitor for Health and Wellness Now Available in the U.S., from 9:00AM ET on Thursday Sep 05, 2024 by Dow Jones

  9:00AM ET on Thursday Sep 05, 2024 by Dow Jones
  Companies Mentioned: ABT
  diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004 May 18;140(10):769-77. doi: 10.7326/0003-4819-140-10-200405180-00006. PMID: 15148063. https://pubmed.ncbi.nlm.nih.gov/15148063/ 11. Bueno NB, et al. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013 Oct;110(7):1178-87. https://pubmed.ncbi.nlm.nih.gov/23651522/ 12. Chekima K, at al. Utilising a Real-Time Continuous Glucose Monitor as Part of a Low Glycaemic Index and Load Diet and Determining Its Effect on Improving Dietary Intake, Body Composition and Metabolic Parameters of Overweight and Obese Young Adults: A Randomised Controlled Trial. Foods. 2022 Jun 15;11(12):1754. https://pubmed.ncbi.nlm.nih.gov/35741952/ 13. Gangwisch JE, et al. High glycemic index and glycemic load diets as risk factors for insomnia: analyses from the Women's Health Initiative. Am J Clin Nutr. 2020 Feb 1;111(2):429-439. https://pubmed.ncbi.nlm.nih.gov/31828298/ 14. Yoda K, et al. Association between poor glycemic control, impaired sleep quality, and increased arterial thickening in type 2 diabetic patients. PLoS One. 2015 Apr 14;10(4):e0122521. https://pubmed.ncbi.nlm.nih.gov/25875738/ 15. Tsereteli N, et al. Impact of insufficient sleep on dysregulated blood glucose control under standardised meal conditions. Diabetologia. 2022 Feb;65(2):356-365. https://pubmed.ncbi.nlm.nih.gov/34845532/ 16. McConnon A, et al. Experience and acceptability of diets of varying protein content and glycemic index in an obese cohort: results from the Diogenes trial. Eur J Clin Nutr. 2013 Sep;67(9):990-5. https://pubmed.ncbi.nlm.nih.gov/23778783/ 17. Breymeyer KL, et al. Subjective mood and energy levels of healthy weight and overweight/obese healthy adults on high-and low-glycemic load experimental diets. Appetite. 2016 Dec 1;107:253-259. https://pubmed.ncbi.nlm.nih.gov/27507131/